TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T83193	Transient receptor potential cation channel V1	B61ZLR	19(S)-Heyneanine	Investigative	44566752	C22H28N2O4	384.5	C[C@@H]([C@H]1C[C@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC)O	IC50 > 200000 nM	Non binder
T83193	Transient receptor potential cation channel V1	B6OP8A	Benzyl isothiocyanate	Investigative	2346	C8H7NS	149.21	C1=CC=C(C=C1)CN=C=S	EC50 = 223000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BBQZ70	Methyl (1S,14R,16S,17S)-16-ethyl-7-methoxy-3-(methoxymethyl)-10,12-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2,4(9),5,7-tetraene-1-carboxylate	Investigative	118711168	C23H30N2O4	398.5	CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CN4C3=C(C5=C4C=C(C=C5)OC)COC)C(=O)OC	IC50 > 200000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BD8E6J	Nobilamide A	Investigative	53259578	C42H59N7O10	822	C/C=C(/C(=O)O)\\NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)C	IC50 = 1665000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BF58QW	(2R)-2-[[(2R)-2-Acetamido-3-phenylpropanoyl]amino]-N-[(2S)-1-[[(3Z,6S,9S,12R,13R)-3-ethylidene-6,13-dimethyl-2,5,8,11-tetraoxo-9-propan-2-yl-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpentanamide	Investigative	54587294	C42H57N7O9	803.9	C/C=C\\1/C(=O)O[C@@H]([C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C)C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC3=CC=CC=C3)NC(=O)C)C	IC50 = 1320000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BJK5U4	Chembl4226595	Investigative	21404983	C13H19NO3	237.29	CC(C)(C)C(=O)NCCC1=CC(=C(C=C1)O)O	EC50 > 500000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BM2CE0	[2-[2-(5-Hydroxy-1H-indol-3-yl)ethylcarbamoyl]phenyl] acetate	Investigative	118723540	C19H18N2O4	338.4	CC(=O)OC1=CC=CC=C1C(=O)NCCC2=CNC3=C2C=C(C=C3)O	IC50 = 203000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BWQ2K7	Nobilamide B	Investigative	53257733	C43H61N7O10	836	CCC(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N/C(=C\\C)/C(=O)O	IC50 = 275000 nM	Non binder
T83193	Transient receptor potential cation channel V1	BZ96QX	(2R)-N-[(2S)-1-[[(3Z,6S,9S,12R,13R)-3-Ethylidene-6,13-dimethyl-2,5,8,11-tetraoxo-9-propan-2-yl-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2R)-3-phenyl-2-(propanoylamino)propanoyl]amino]pentanamide	Investigative	54587295	C43H59N7O9	818	CCC(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](OC(=O)/C(=C/C)/NC(=O)[C@@H](NC(=O)[C@@H](NC3=O)C(C)C)C)C	IC50 = 227000 nM	Non binder